NCT04045496
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04045496
Title A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jacobio Pharmaceuticals Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
HealthONE Clinic Services Oncology-Hematology Denver Colorado 80202 United States Details
Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
The University of Texas M. D. Anderson Cancer Center Houston Texas 77030 United States Details
Washington University School of Medicine Seattle Washington 63110 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field